Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation, AutologousBone and BonesTransplantation ConditioningLiver TransplantationTransplantation ChimeraWhole-Body IrradiationGraft SurvivalTissue DonorsLeukemiaHematopoietic Stem CellsTransplantation, IsogeneicAnemia, AplasticKidney TransplantationBusulfanHistocompatibility TestingStem Cell TransplantationBone Marrow DiseasesHematologic NeoplasmsHistocompatibilityBone Marrow PurgingRecurrenceTreatment OutcomeBone Marrow ExaminationBone RemodelingGraft RejectionImmunosuppressive AgentsTransplantation ImmunologyLeukemia, Myeloid, AcuteMice, Inbred C57BLCyclophosphamideRemission InductionBone Marrow NeoplasmsHematopoiesisGraft vs Tumor EffectLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHeart TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsCombined Modality TherapyRadiation ChimeraLymphocyte DepletionAcute DiseaseImmunosuppressionLeukemia, MyeloidLung TransplantationSurvival AnalysisT-LymphocytesMultiple MyelomaRetrospective StudiesMyelodysplastic SyndromesBone DensityHepatic Veno-Occlusive DiseasePeripheral Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorGraft vs Leukemia EffectAntigens, CD34Lymphoma, Non-HodgkinCyclosporineHLA AntigensHematopoietic Stem Cell MobilizationSurvival RateColony-Forming Units AssayLymphocyte TransfusionOrgan TransplantationGraft vs Host ReactionNuclear FamilyBone ResorptionCell DifferentiationCord Blood Stem Cell TransplantationMelphalanAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionMice, Inbred BALB CDisease-Free SurvivalChimeraFollow-Up StudiesSpleenCell TransplantationMyeloablative AgonistsCytomegalovirus InfectionsCells, CulturedIslets of Langerhans TransplantationHematologic DiseasesBlood CellsFlow CytometryLymphomaSevere Combined ImmunodeficiencyPancreas TransplantationBone NeoplasmsTransplantationVidarabinePancytopeniaCell SeparationNeoplasm, Residual